Pharmaceuticals
Finished dosage forms, hospital injectables, specialty medicines and selected APIs across regulated supply channels.

Healthcare sectors
ORBIWAY supports priority healthcare categories while calibrating qualification, logistics and market-entry requirements to the risk profile of each product.
Request a product assessmentSector portfolio
Finished dosage forms, hospital injectables, specialty medicines and selected APIs across regulated supply channels.
Biological products, biosimilar opportunities and temperature-sensitive programmes requiring enhanced coordination.
Clinical equipment and procedure-specific devices sourced against technical, regulatory and service requirements.
High-volume and specialist disposable products for hospitals, procurement groups and public-sector programmes.
Analyzers, reagents, rapid tests and laboratory consumables with attention to compatibility and handling conditions.
Enteral, specialist and condition-specific nutrition for institutional and high-acuity care requirements.
Selected professional-use products supported by channel strategy, quality review and controlled market development.
Focused availability intelligence and rapid mobilisation for critical or temporarily constrained products.
Procurement pathways
Forecast-led sourcing with agreed documentation, manufacturing lead time and delivery cadence.
Item-level eligibility, bid documentation, commercial validity and post-award mobilisation.
Accelerated stock identification with origin, batch, expiry and import feasibility reviewed in parallel.
Manufacturer selection, dossier readiness, pricing logic, local representation and launch planning.
Qualification note
References to GMP, GDP, CE, MDR, ISO, WHO prequalification or other frameworks describe evidence that may be required for a mandate. They do not imply blanket certification of ORBIWAY or automatic eligibility of any supplier.
Start a focused conversation
Include the destination market, quantity, timeline and mandatory approvals so the opportunity can be screened against the right sector pathway.